Maria Rosa Ballester
0000-0002-0472-9558
1 paper found
Refreshing results…
An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of Trichuris trichiura and other STH infections. ALIVE trial protocol
Missing publications? Search for publications with a matching author name.